arXiv:2606. 31085v1 Announce Type: new Abstract: Drug-drug interaction (DDI) prediction is essential for medication safety, yet it requires reasoning over heterogeneous biomedical evidence whose relevance changes across interaction mechanisms.
By Zhenqian Shen, Yu Liu, Xiaoyi Fu, Quanming Yao
arXiv:2606. 28692v1 Announce Type: new Abstract: Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy.
By Shanghua Gao, Ayush Noori, Richard Zhu, Curtis Ginder, Zhenglun Kong, Xiaorui Su, Justin Kauffman, Benjamin S. Glicksberg, Joshua Lampert, Ankit Sakhuja, Ashwin Sawant, ATHENA-R1 Evaluation Consortium, David A. Clifton, Noa Dagan, Ran Balicer, Marinka Zitnik
arXiv:2609.06779v1 Announce Type: cross
Abstract: Drug repurposing aims to identify new therapeutic uses for existing compounds and, compared with de novo drug discovery, offers a faster and more cos...
By Zijie Liu, Hongxuan Li, Zhen Tan, Jinhao Duan, Baixiang Huang, Zunpeng Liu, Kai Shu, Tianlong Chen
arXiv:2608.28612v1 Announce Type: new
Abstract: Generating professional scholarly content, such as peer reviews and rebuttals, requires an intricate synergy between domain reasoning and factual groun...
By Xuerui Su, Liya Guo, Qizhi Pei, Qipeng Guo, Zhongbo Tian, Lijun Wu, Kai Chen, Zun Wang
arXiv:2609.22104v1 Announce Type: new
Abstract: As automated scientific discovery advances, Large Language Models (LLMs) can now generate research ideas at an unprecedented scale, shifting the bottle...
By Rongcan Pei, Fang Guo, Qinglin Qi, Qi Zhu, Yun Luo, Jianhao Yan, Minjun Zhu, Qiujie Xie, Dehong Zheng, Yue Zhang
arXiv:2607. 02983v1 Announce Type: new Abstract: Recent reasoning-centric Large Language Models (LLMs) have made significant strides, yet they predominantly operate on a passive-inference pattern that assumes complete information.
By Shengyi Hua, Kangzhe Hu, Conghui He, Xiaofan Zhang, Shaoting Zhang